Effects of subfascial infiltration of 0.25% bupivacaine versus N/saline in elective abdominal surgery: a randomised controlled trial.

ISRCTN ISRCTN12037208
DOI https://doi.org/10.1186/ISRCTN12037208
Secondary identifying numbers N0234126586
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
25/10/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr A R Dixon
Scientific

Department of Surgery
North Bristol NHS Trust
Frenchay Hospital
Frenchay
Bristol
BS16 1ND
United Kingdom

Phone +44 (0)117 970 1212
Email anthony.dixon@north-bristol.swest.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific titleEffects of subfascial infiltration of 0.25% bupivacaine versus N/saline in elective abdominal surgery: a randomised controlled trial.
Study objectivesThe effects of subfascial infiltration of 0.25% bupivacaine versus N/saline in elective abdominal surgery: a randomised controlled trial.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Post-operative pain
InterventionPatients will undergo a simple non-invasive pulmonary function test carried out at the patients bedside and repeated each morning for the first 7 days postoperatively.

Added August 2008: trial stopped.
Intervention typeOther
Primary outcome measureSurgery pain scores.
Secondary outcome measuresNot provided at time of registration
Overall study start date30/05/2003
Completion date30/10/2003
Reason abandoned (if study stopped)Lack of staff

Eligibility

Participant type(s)Patient
Age groupNot Specified
Lower age limit18 Years
Upper age limit90 Years
SexNot Specified
Target number of participants80
Key inclusion criteriaAll patients who require abdominal surgery (midline laparotomy) and are aged between 18-90 will be entered into the study excluding the following: History of drug abuse, chronic pain, regular medication with opioids/non-steroidal anti-inflammatory drugs (NSAIDs), diabetes, morbid obesity, unable to use patient controlled analgesia (PCA). A total of 80 patients will be studied, 40 in each group (those receiving a placebo, and those receiving 0.25% bupivacaine).
Key exclusion criteriaNot provided at time of registration
Date of first enrolment30/05/2003
Date of final enrolment30/10/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Surgery
Bristol
BS16 1ND
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

North Bristol NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan